Edwards Lifesciences Corporation Inventory Write-down
Edwards Lifesciences Corporation (EW) reported Inventory Write-down of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2022-02-14
- Edwards Lifesciences Corporation inventory write-down for the quarter ending 2020-12-31 was $0.00.
- Edwards Lifesciences Corporation inventory write-down for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation inventory write-down for the quarter ending 2019-12-31 was $0.00.
- Edwards Lifesciences Corporation inventory write-down for the quarter ending 2019-09-30 was $26.90M.
- Edwards Lifesciences Corporation inventory write-down for fiscal 2021 was $0.00.
- Edwards Lifesciences Corporation inventory write-down for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Edwards Lifesciences Corporation inventory write-down for fiscal 2019 was $73.10M.
- Edwards Lifesciences Corporation inventory write-down for fiscal 2018 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 3 month as first filed | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-14 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $0.00 derived: sum of 2 quarters · filed 2022-02-14 | $0.00 10-K · filed 2022-02-14 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $0.00 10-Q · filed 2020-10-26 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-27 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $26.90M derived: sum of 2 quarters · filed 2022-02-14 | $73.10M derived: sum of 3 quarters · filed 2022-02-14 | $73.10M 10-K · filed 2022-02-14 | |
| 2019-09-30 | $26.90M 10-K · filed 2021-02-12 | $10.30M 10-Q · filed 2019-10-25 | $73.10M derived: sum of 2 quarters · filed 2021-02-12 | $73.10M 10-Q · filed 2020-10-26 | |
| 2019-06-30 | $46.20M 10-K · filed 2021-02-12 | $46.20M 10-Q · filed 2020-07-27 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-12 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |